Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Icahn School of Medicine at Mount Sinai
With
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Newly diagnosed patients with stage 1 through 3a Breast Cancer scheduled to receive a 12-week, 16-week, 18-week, 20-week, or 24-week chemotherapy regimen, adjuvant, neoadjuvant, or already receiving chemotherapy.
MSH, COH and MSK can recruit participants schedule to go on aromatase inhibitors after treatment.
Currently over the age of 18.
English language proficient.
Able to provide informed consent.
You may not be if
Under age 18
Breast cancer patients scheduled to undergo chemo regimen other than the 12-week, 18-week, 20-week, or 24-week regimen
Stage 3B breast cancer inflammatory or Stage 4 breast cancer
Pregnancy
Currently employed in night shift work
Confounding underlying medical illnesses which may cause fatigue (e.g., severe Anemia not controlled by medication, per self-report corroborated by medical chart review (e.g., Hb\<10gm/dl))
Eye Diseases which limit the ability of light to be processed (e.g., untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems or retina damage)
Secondary cancer diagnosis (prior or current) within the past 5 years
Severe sleep disorders (e.g., Narcolepsy)
Self- reported history of bipolar disorder or manic episodes (which is a contra-indication for light treatment)
Severe psychological impairment (e.g., hospitalization for depressive episode in the past 12 months
Previous use of light therapy to alleviate fatigue or depressive symptoms
Lives outside of the United States throughout the duration of study
Clareo Health | Systematic Light Exposure for Fatigue in Breast Cancer Patients
